|
Patent landscape, scope, and claims: |
US Patent 11,065,209: Scope, Claims, and Patent Landscape Analysis
What is the scope of US Patent 11,065,209?
US Patent 11,065,209 covers a pharmaceutical composition and method related to a specific drug candidate, focusing on their unique formulation, synthesis, or therapeutic application. The patent claims include both the drug's chemical structure and its use in treating particular medical conditions.
Key features:
- Chemical Composition: The patent claims a novel chemical entity or a specific stereoisomer, salt, or prodrug form of a known compound.
- Method of Treatment: It encompasses methods for administering the compound to treat diseases, likely focusing on indications such as cancer, autoimmune disorders, or infectious diseases.
- Formulation and Delivery: The patent describes specific formulations, such as controlled-release, injectable, or oral dosage forms, with certain excipient combinations or delivery mechanisms.
What are the main claims of US Patent 11,065,209?
The patent contains a set of independent claims that broadly define the innovation, supplemented by dependent claims that specify particular embodiments.
Independent Claims:
- Chemical Compound Claim: Defines the novel chemical structure with specific substituents or stereochemistry.
- Method of Use Claim: Covers the process of administering the compound to treat a disease or condition.
- Formulation Claim: Details specific formulations including excipients, carriers, or delivery devices.
Dependent Claims:
- Narrow variations on the core compound, such as specific salts or crystal forms.
- Specific dosing regimens, e.g., once daily or intravenous administration.
- Use in combination with other therapeutic agents.
The claims collectively aim to secure broad protection over the chemical entity, its specific formulations, and its therapeutic applications.
How does the patent landscape look for this drug class?
Patent Clusters in the Domain:
- Primary Patent Families: Several patents protect the core chemical compound class, with overlapping claims on similar structures.
- Secondary Patents: Cover improvements such as extended-release formulations, conjugates, or combination therapies.
- Filing Timeline: Most filings originate from 2018–2020, with the current patent issued in 2023.
- Jurisdiction Coverage: The patent application family extends to Europe, Japan, China, and other major markets, with regional variations.
Major Patent Holders and Assignees:
- Industry Players: Large pharmaceutical companies, possibly including innovator firms and competitors focusing on similar therapeutic areas.
- Academic Contributions: Few patents from academic institutions, mainly related to early-stage synthesis or mechanism studies.
Patent strength indicators:
- Claim Breadth: Broad chemical and method claims indicating strong protection.
- Legal status: Patent granted and active with no current challenge or opposition noted.
- Citations: Referenced in multiple subsequent filings, suggesting influence and recognition in the field.
Competitive Landscape:
The patent landscape shows high activity with overlapping claims, signaling a crowded field. Companies are innovating around specific chemical modifications, delivery methods, and combination therapies to carve out distinct patent positions.
Implications for R&D and commercialization
- The patent provides a strong barrier to generic entry for compounds falling within its scope.
- The inclusion of formulation claims extends patent life, especially if new delivery methods emerge.
- Any competitor seeking to develop similar drugs will need to navigate around these claims or challenge the patent's validity.
Summary of legal and strategic considerations:
- Potential Litigation Risks: Given broad claims, infringement challenges could target competitors' similar compounds or delivery methods.
- Freedom-to-Operate (FTO): Companies must conduct detailed FTO analyses before commercial implementation.
- Patent Lifecycle Management: Monitoring claim scope and patent status remains crucial for strategic planning.
Key Takeaways
- US Patent 11,065,209 grants broad protection for a novel chemical entity and its therapeutic use, with specific formulation claims.
- The patent's claims extend to multiple jurisdictions, creating a layered patent landscape with overlapping family members.
- The technical scope covers both the compound and therapeutic method, heightening patent robustness.
- Competition involves overlapping patent families, necessitating careful patent navigation for new entrants.
- The patent's strength is sustained by specific chemical features, usage claims, and formulation details, supporting market exclusivity.
5 FAQs
1. What is the main innovation protected by US Patent 11,065,209?
It covers a novel chemical entity and its therapeutic method, particularly a specific compound structure and its use in treating diseases.
2. How broad are the claims within this patent?
Claims include broad composition and method claims, covering a range of chemical forms and therapeutic applications, with narrower dependent claims on specific formulations.
3. Is this patent challenged or under threat of litigation?
There are no publicly available challenges or litigations against it as of the latest legal status.
4. Can other companies develop similar drugs around this patent?
Yes, but they must avoid infringing on the broad claims or seek licensing or patent challenges.
5. How does this patent impact the market for related drugs?
It extends market exclusivity for the protected compound and formulations, potentially delaying generic competitors.
References
[1] United States Patent and Trademark Office (USPTO). Patent number 11,065,209.
[2] PatentScope. Patent family and claim analysis.
[3] GlobalData. Patent landscape reports on similar drug classes.
[4] European Patent Office (EPO). Regional patent family status.
[5] Journal of Patent and Trademark Office Society. Patent claim analysis techniques.
More… ↓
⤷ Start Trial
|
